Everolimus-Eluting Stents vs BMS in Octogenarians
In patients ≥80 years of age undergoing stent placement for symptomatic coronary disease, DES, when compared with BMS, had no impact on all-cause death, CVA, and major hemorrhage but reduced the incidence of MI and TVR.
Conclusions
In patients ≥80 years of age undergoing stent placement for symptomatic coronary disease, DES, when compared with BMS, had no impact on all-cause death, CVA, and major hemorrhage but reduced the incidence of MI and TVR.
Source...